Background Baseline values and the change of platelet count (PLT) during disease were
reported to be associated with prognosis of patients with cancer and intensive care …

Objective To assess whether mean platelet volume (MPV) is associated with functional
outcome in patients with aneurysmal subarachnoid hemorrhage (aSAH). Methods We …

Pathophysiological processes following aneurysmal subarachnoid hemorrhage (aSAH)
include upregulated underlying systemic inflammation, which is reflected by changes in …

This study aimed to identify the association between the platelet-to-white blood cell ratio
(PWR) and outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). Data …

Background Aneurysmal subarachnoid hemorrhage (aSAH) is both a hypercoagulable and
inflammation state in which many biomarkers have been studied. Activated platelets have …

Microthrombosis after aneurysmal subarachnoid hemorrhage (aSAH) is considered to
initiate neuroinflammation, vessel remodeling, and blood-brain barrier leakage. We aimed to …

Background Delayed cerebral ischemia (DCI) is a major cause of disability after aneurysmal
subarachnoid hemorrhage (aSAH). Activated platelets are surrogate markers for DCI …

The aim of study was aimed to investigate associations of platelet-to-neutrophil ratio (PNR)
and platelet-to-lymphocyte ratio (PLR) on admission with clinical outcomes of patients with …

Patients with subarachnoid hemorrhage (SAH) who are using antiplatelet drugs prior to their
hemorrhage, often receive platelet transfusions to reverse antiplatelet effects prior to life …

Objective This investigation sought to explore the association between postoperative/
preoperative platelet ratio (PPR) and the incidence of unfavorable outcomes within 90 days …